The Global Vaccine Adjuvant Market was worth $472 million in 2016 and estimated to be growing at a CAGR of 10.8%, to reach $788.21 million by 2021. The global vaccine adjuvants market comprises of veterinary and human adjuvants which are used to increase the efficiency of vaccines. Vaccine adjuvants are accredited with assisting to boost the immune response in the host post-vaccination. Immunologists and infectious disease specialists are in covenant over the advantageous uses of adjuvants ... Read more
Adjuvants are compounds that enhance the body immunogenic response against antigens. Hence, adjuvants are vaccines to extend their ability to induce long-run protection against infections. Immunogen adjuvants are in the zone of development, and presently Aluminum salts and MF59 are the sole adjuvants found possible for human use. R&D for potent immunogen adjuvants is progressing positively in the event of new-generation vaccines. Modern vaccines ... Read more
